Lexicon Pharmaceuticals Shares Up 32.3% Since SmarTrend's Buy Recommendation (LXRX)

SmarTrend identified an Uptrend for Lexicon Pharmaceuticals (NASDAQ:LXRX) on March 2nd, 2016 at $11.30. In approximately 4 months, Lexicon Pharmaceuticals has returned 32.27% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.